Ignite Creation Date:
2025-12-24 @ 1:18 PM
Ignite Modification Date:
2025-12-28 @ 5:29 AM
Study NCT ID:
NCT00148395
Status:
COMPLETED
Last Update Posted:
2008-04-22
First Post:
2005-09-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Randomized Phase III-Study in Stage IIIb and IV Non-Small-Cell Lung Cancer. Sequential Single-Agent vs. Double-Agent vs. Triple-Agent Therapy.
Sponsor:
Aktion Bronchialkarzinom e.V.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2002-06
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
2008-04
Completion Date Type:
ACTUAL
First Submit Date:
2005-09-07
First Submit QC Date:
None
Study First Post Date:
2005-09-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2008-04-21
Last Update Post Date:
2008-04-22
Last Update Post Date Type:
ESTIMATED